ABOUT US
We are driven by a commitment to quality, innovation, and ethical healthcare. This page reflects who we are, what we stand for, and how we work to make a lasting impact in sports medicine.
Restore infinite mobility to patients
Accelerate rehabilitation for an active lifestyle
Our vision is to be a global leader in Sports Medicine,
delivering disruptive solutions that empower surgeons and enhance patient outcomes.
Our mission is to restore mobility and improve recovery for patients with soft tissue injuries
by providing innovative, less invasive treatment solutions.

Innovation
Pioneering innovative solutions that shape the future of sports medicine.

Know-How
Leveraging long-standing expertise and decades of experience to deliver high quality products.

Dynamism
A modern company on the move with energy and adaptability to drive progress and achieve excellence.

Togetherness
Fostering collaboration
and unity with passion and determination to advance medical science.
Long-standing expertise in sports medicine
Our governance
At Movmedix, our leadership team brings decades of multidisciplinary experience and deep expertise to the forefront of sports medicine. Committed to innovation, quality of care, and supporting diverse patient journeys, our leaders are shaping the future of sports medicine with a bold, visionary approach.
Under the guidance of Hervé Legrand, CEO of Movmedix, the team leverages extensive real-world experience to deliver a holistic approach that benefits both patients and healthcare professionals.

Hervé Legrand
Chief Executive Officer

Vanessa Bailly
Deputy General Manager & Resources Director

Stéphane Revaux
Operations Director

Jean-Philippe Leal
International Sales Director

Lionel Robbe
R&D Director
From start to finish: Quality in every detail
Bringing high quality solutions
At Movmedix, we develop cutting-edge solutions to improve patients’ quality of life. Our portfolio includes synthetic ligaments, fixation systems, and surgical instruments, providing a holistic, end-to-end approach in sports medicine.
The LARS® ligament, made from biocompatible, non-resorbable polyethylene terephthalate (PET), has been handcrafted in Arc-sur-Tille, France, for over 30 years, combining precision, durability, and clinical reliability.
Our dedicated teams are committed to delivering high-quality products and services to patients, surgeons, and healthcare professionals, ensuring quality is a core value in every aspect of our organization.
French legacy with a rigorous quality culture & standards
Our manufacturing operates in state-of-the-art cleanrooms, adhering to the strictest industry standards and subject to frequent external audits across multiple regulatory regions. Every product is designed to be safe, reliable, and fully compliant with local and international regulations.
This strong quality culture, rooted in French medical engineering, allows us to continuously adapt to the evolving global regulatory landscape while delivering solutions that meet the highest expectations of surgeons and patients worldwide.
Ethical business conduct is at the heart of everything we do
Business Conduct & Compliance
As a manufacturer of medical devices operating in an international and highly regulated environment, we are fully committed to upholding the highest standards of integrity, transparency, and responsibility in all our relationships. We recognize that adherence to ethical standards and compliance with applicable laws is critical to its own success and to the medical device industry’s ability to continue its collaboration with healthcare professionals, supporting patients, and working alongside our distributors worldwide. Our actions are guided by clear principles and codes of conduct, ensuring that trust remains the foundation of our partnerships and innovation.
Our Journey
Movmedix, 30 years of Know-How
Founded on a commitment to innovation and excellence, Movmedix has a rich and unique history of advancing sports medicine solutions. From our early beginnings to becoming a trusted global leader, we have continuously evolved, developing cutting-edge technologies that empower surgeons and patients.
The company is founded by Dr Jacques-Philippe Laboureau under the name of L.A.R.S., introducing the 3rd generation of artificial ligaments LARS®.
LARS obtains the CE marking and is commercially launched in most European countries.
The company expands outside Europe and China, entering some of the major international markets such as Australia, Canada or Taiwan.
The company starts the development of a 4th generation of artificial ligament in collaboration with Paris XIII University.
The company starts the development of the 5th generation of artificial ligaments with the financial support of BPI.
L.A.R.S. is acquired by Huaxing HC fund and becomes movmedix.
The 4th generation of bioactive ligament is implanted in Italy as part of a clinical investigation.
Committed to communities through responsible and transparent actions
Listening, learning, and acting for a better tomorrow
As a leader in our market, we make it our mission to deliver innovative, high-quality orthopedic solutions that restore active living for people around the world. Our clinician customers and their patients are at the heart of everything we do. But we also believe that we have a broader responsibility to take into account the positive effect we seek to have on our employees, and the environment and the communities where we live and work.
Let’s contribute to advancement of sports medicine worldwide
Explore opportunities
to join us
Join Movmedix and become part of a passionate, innovative team dedicated to shaping the future of sports medicine. Your work will help improve patient outcomes, enhance surgical practices, and drive innovation in medical solutions.
We are committed to expanding our global reach and amplifying the positive impact of our work on patients, healthcare professionals, and communities worldwide. Together, we can make a meaningful difference in the lives of people around the globe.



